Global Genomics Market

1 INTRODUCTION OF GLOBAL GENOMICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GENOMICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL GENOMICS MARKET, BY TECHNOLOGY
5.1 Overview
5.2 Sequencing
5.3 Microarray
5.4 PCR
5.5 Nucleic Acid Extraction and Purification
5.6 Other Technologies

6 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Instruments and Systems
6.3 Consumables
6.4 Services

7 GLOBAL GENOMICS MARKET, BY APPLICATION
7.1 Overview
7.1.1 Diagnostics
7.1.2 Cancer Diagnostics
7.1.3 Monogenic (Mendelian) Disorders
7.1.4 Other Diagnostic Applications
7.1.4.1 Common Diseases and Complex Disorders
7.1.4.2 Movement Disorders
7.1.4.3 HIV
7.2 Drug Discovery and Development
7.3 Precision Medicine
7.4 Agriculture & Animal Research
7.5 Other Applications

8 GLOBAL GENOMICS MARKET, BY PROCESS
8.1 Overview
8.2 Sequencing
8.3 Library Preparation
8.4 Data Analysis

9 GLOBAL GENOMICS MARKET, BY END USER
9.1 Overview
9.2 Research Centers and Academic & Government Institutes
9.3 Hospitals and Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users

10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

11 GLOBAL GENOMICS MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Illumina
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Agilent Technologies
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Thermo Fisher Scientific
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Eurofins Scientific
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 Qiagen
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 GE Healthcare
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 F. Hoffmann-La Roche
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Oxford Nanopore Technologies
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Bio-Rad Laboratories
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 BGI
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Eppendorf
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Pacific Biosciences of California
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Danaher
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

13 Appendix
13.1 Related Reports